Brainstorm
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
Buy Now for $21.99
No valid payment method on file.
We are sorry. We are not allowed to sell this product with the selected payment method
-
Narrated by:
-
Tim Carroll
About this listen
The incredible story of 2024 Co-Australian of the Year, Richard Scolyer, as he uses his groundbreaking melanoma science to fight his own 'incurable' diagnosis with brain cancer.
A dedicated doctor. A devastating diagnosis. A chance for a medical revolution.
Skin cancer is this country's most common cancer, and melanoma the deadliest form of it. Richard Scolyer, together with his colleagues at Melanoma Institute Australia, has dedicated years to groundbreaking research and succeeded in transforming even the most advanced cases of melanoma into a largely curable disease.
Then last year, at the peak of his life, Richard was devastated when he was diagnosed with an incurable brain cancer.
As a world-leading clinician and cancer researcher, Richard was never going to accept the status quo—including a medical approach unchanged in nearly two decades and an expectation of little more than a year to live. He instead chose to undertake world-first experimental treatment for his brain cancer, based on melanoma science. His brave decision could shorten or save his life—the only certainty is that it will push the brain cancer field forward and ultimately help save the lives of others.
This is his story.
What listeners say about Brainstorm
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
-
Overall
-
Performance
-
Story
- gregory Ross
- 05-11-2024
We all need inspiration
This piece well projects the extraordinariness of what and how an ordinary but extraordinary cancer patient can be an inspiration to others but recognises the importance on science, science has helped to treat and sometimes cure thousands of of cancer patients, including me 12 years ago.
Something went wrong. Please try again in a few minutes.
You voted on this review!
You reported this review!